Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Androgen Treatment for COVID-19

NCT04446429 is registered in ClinicalTrials.gov with Applied Biology, Inc. as lead sponsor.

NCT NCT04446429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04446429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Androgen Treatment for COVID-19
Lead sponsor
Applied Biology, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 21, 2020
Completion date
January 21, 2021
Enrollment
268 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia, benign prostatic hyperplasia, covid-19, prostate cancer, sars (severe acute respiratory syndrome), sars-cov2